Interestingly, the sensitivity of the various lymphocyte populations to ionizing radiation in vivo was variable: the tumor infiltrating FOXP3+ Treg cells were more resistant compared with CD8+ T cells, and may dominate the tumor milieu after radiotherapy (25). The gene discussed is FOXP3; the disease is neoplasm.